Follow The Filings

KMTS Kestra Medical Technologies

Kestra Medical Technologies earnings company data as of 4:51 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 10 Dec EPS — — —
Rev — — —
FY2027 Q1 14 Sep EPS -0.63 -0.75 Miss
Rev $29.0M $31.0M Beat +6.9%

Insider trades

Open-market buys and sales by KMTS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KMTS insider trades
  • $200K bought by 1 insider
  • None no sales outside a trading plan
  • $7.3M sold by 3 insiders under 10b5-1 plans
  1. Traci S Umberger See Remarks
    Planned sale
    $2.7M 100,000 shares at $27.18 34% of stake
    Traded Oct 21 Filed Oct 22
  2. Brian Daniel Webster See Remarks
    Planned sale
    $443K 15,000 shares at $29.56 3.3% of stake
    Traded Oct 20 Filed Oct 22
  3. Brian Daniel Webster See Remarks
    Planned sale
    $412K 15,000 shares at $27.48 3.2% of stake
    Traded Aug 17 Filed Aug 18
  4. Vaseem Mahboob CFO
    Planned sale
    $680K 26,287 shares at $25.88 30% of stake
    Traded Aug 7 Filed Aug 11
  5. Vaseem Mahboob CFO
    Planned sale
    $99K 3,915 shares at $25.17 4.3% of stake
    Traded Aug 4 Filed Aug 6
  6. Brian Daniel Webster See Remarks
    Planned sale
    $337K 15,000 shares at $22.44 2.6% of stake
    Traded Jul 15 Filed Jul 17
  7. Brian Daniel Webster See Remarks
    Planned sale
    $312K 15,000 shares at $20.81 3.7% of stake
    Traded Jun 15 Filed Jun 17
  8. Brian Daniel Webster See Remarks
    Planned sale
    $314K 15,000 shares at $20.96 4.3% of stake
    Traded May 15 Filed May 18
  9. Brian Daniel Webster See Remarks
    Planned sale
    $301K 15,000 shares at $20.04 4.1% of stake
    Traded Apr 15 Filed Apr 16
  10. Raymond W Cohen Director
    Buy
    $200K 10,000 shares at $19.98 +24% to stake
    Traded Mar 26 Filed Mar 30
  11. Brian Daniel Webster See Remarks
    Planned sale
    $304K 15,000 shares at $20.27 3.9% of stake
    Traded Mar 17 Filed Mar 19
  12. Brian Daniel Webster See Remarks
    Planned sale
    $384K 15,000 shares at $25.60 3.8% of stake
    Traded Feb 17 Filed Feb 19
  13. Brian Daniel Webster See Remarks
    Planned sale
    $342K 15,000 shares at $22.80 3.7% of stake
    Traded Jan 15 Filed Jan 20
  14. Traci S Umberger See Remarks
    Planned sale
    $280K 10,500 shares at $26.69 7.1% of stake
    Traded Dec 29, 2025 Filed Dec 31, 2025
  15. Brian Daniel Webster See Remarks
    Planned sale
    $399K 15,000 shares at $26.59 3.5% of stake
    Traded Dec 29, 2025 Filed Dec 31, 2025

Also filed in the last 12 months, not counted as buying or selling: 27 sales to cover taxes, 20 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 5.07
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 1.01,1.02,2.02,2.03,9.01
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.